First Generic of Strattera for the Treatment of ADHD Approved
Apotex, Teva, Aurobindo and Glenmark today gained approval to market atomoxetine in multiple strengths. Kathleen Uhl, M.D., director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research said “Quickly bringing generics to market so patients have more options to treat their conditions is a top…